M&R Capital Management’s Imunon IMNN Stock Holding History

M&R Capital Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$353	Hold	26	–	–	﹤0.01%	564
2024 Q2	$386	Hold	26	–	–	﹤0.01%	530
2024 Q1	$546	Hold	26	–	–	﹤0.01%	531
2023 Q4	$226	Hold	26	–	–	﹤0.01%	628
2023 Q3	$327	Hold	26	–	–	﹤0.01%	607
2023 Q2	$429	Hold	26	–	–	﹤0.01%	601
2023 Q1	$412	Hold	26	–	–	﹤0.01%	594
2022 Q4	$449	Hold	26	–	–	﹤0.01%	586
2022 Q3	$0	Hold	26	–	–	﹤0.01%	441
2022 Q2	$0	Hold	26	–	–	﹤0.01%	438
2022 Q1	$1K	Hold	26	–	–	﹤0.01%	420
2021 Q4	$2K	Hold	26	–	–	﹤0.01%	392
2021 Q3	$4K	Hold	26	–	–	﹤0.01%	379
2021 Q2	$6K	Hold	26	–	–	﹤0.01%	363
2021 Q1	$6K	Buy	+26	New	+$8.73K	﹤0.01%	357

Other funds holding IMNN

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

M&R Capital Management's IMNN Position: Q3 2024 in Review

M&R Capital Management held its Imunon (IMNN) position steady in Q3 2024 at 26 shares worth $353. The position accounts for ﹤0.01% of the portfolio, ranked #564.

M&R Capital Management first reported a position in IMNN in Q1 2021 and has held it in 15 quarters since. The position peaked at $6K in Q2 2021. 18 funds tracked by Wall St. Rank hold IMNN as of Q3 2024.

M&R Capital Management held 26 shares of Imunon worth $353 as of Q3 2024.
M&R Capital Management left its Imunon share count unchanged in Q3 2024.
Imunon made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #564 holding.
M&R Capital Management first reported a position in Imunon in Q1 2021 and has held it in 15 quarters since.
M&R Capital Management's Imunon position peaked at $6K in Q2 2021.
18 funds tracked by Wall St. Rank held Imunon as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.